For Rod and Pura entertainment and real informatio
Post# of 22456
"In addition, the Company has signed a term sheet with a Canada-based biotech company that has identified and has a patent-pending on several biomarker candidates that will be used to develop the TBI POCT."
Quote:
Neurolytixs’ ground-breaking technology is revolutionizing concussion diagnosis. Our proprietary research has identified a number of blood biomarkers that accurately identify brain injury among patients. Developed by Dr. Doug Fraser, a professor, clinician scientist, and Fellow of the Royal College of Physicians and Surgeons of Canada, this technology is the first test of its kind to yield up to 96% accuracy in concussion diagnosis.
https://www.yahoo.com/now/neurolytixs-ground-...00654.html
"
Quote:
Neurolytixs is a truly 'Made in Canada' market disruptor that has global potential." Patented here in Canada and around the world, with plans underway to secure regulatory approval in US and Europe, the product is now moving into large-scale clinical trials."
https://www.neurolytixs.com/about-us/
See the Partners at bottom of page in above link
Neurolytixs Intellectual Property (Patents)
METABOLOMICS PROFILING OF CENTRAL NERVOUS SYSTEM INJURY (2016), WO 2016/149808
DETERMINING CENTRAL NERVOUS SYSTEM INJURY AND RECOVERY (2020), 62/988169
DIAGNOSIS AND THERAPY OF TRAUMATIC BRAIN INJURY (2020), 63/104680
DETERMINING MILD TRAUMATIC BRAIN INJURY, RECOVERY AND TREATMENT (2021), 63/211771